MindWalk Holdings Corp. (NASDAQ: HYFT), a bio-native AI company, today announced B Cell Llama™, a platform for the discovery of VHH nanobodies: the single-domain antibody fragments increasingly ...

Researchers created long noncoding RNA targeting inflammatory pathways. The approach reduced cytokine production in human cell cultures and mouse models, demonstrating a novel strategy for RNA-based ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced that the first patient has been enrolled in its Phase 1 clinical trial evaluating IDE892, an ...

Nina Bauer of FUJIFILM Cellular Dynamics shares insight on addressing challenges and supporting developers heading towards commercialization.

A recent experimental treatment may offer a new method to prevent HIV infection: by combining two antiviral tactics into a single antibody. In laboratory studies, the new molecule forced the virus to ...

South San Francisco, California Tuesday, March 10, 2026, 17:00 Hrs [IST] ...

Scientists have reported a laboratory culture system that can regenerate hair follicles in vitro with functional features normally seen only in living tissue, including follicle downgrowth, hair ...

Scientists developed a new mRNA platform that keeps vaccines and therapies effective in older adults and patients with obesity, where current treatments often lose potency.

Sildenafil – an active ingredient also marketed under the name of Viagra – improves symptoms in patients with Leigh syndrome. This has now been reported in the Cell* journal by researchers at Charité ...

Hello again, everyone. My name is Etzer Darout, one of the senior biotech analysts at Barclays. My pleasure to welcome Xencor to our fireside chat. With us today, we have Bassil Dahiyat, President and ...

Explore the breakthrough of lab-made lncRNA by University of Toronto Engineering for new drug discovery potential.